Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2035
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ischemia Reperfusion Injury, provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The major players in global market include
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Geographically, this report split global into several key Regions, with, Revenue (M USD), market share and growth rate of Ischemia Reperfusion Injury for these regions, from 2025 to 2035 (forecast)
North America
Europe
China
Japan
Southeast Asia
India
RoW
On the basis on the end users/Application, this report covers
Heart Injury
Kidney Injury
Intestine Injury
Other Injury
- 1 Industry Overview
- 1.1 Ischemia Reperfusion Injury Market Overview
- 1.1.1 Ischemia Reperfusion Injury Product Scope
- 1.1.2 Market Status and Outlook
- 1.2 Global Ischemia Reperfusion Injury Market Size and Analysis by Regions (2025-2035)
- 1.2.1 North America Ischemia Reperfusion Injury Market Status and Outlook
- 1.2.2 Europe Ischemia Reperfusion Injury Market Status and Outlook
- 1.2.3 Japan Ischemia Reperfusion Injury Market Status and Outlook
- 1.2.4 China Ischemia Reperfusion Injury Market Status and Outlook
- 1.2.5 Southeast Asia Ischemia Reperfusion Injury Market Status and Outlook
- 1.2.6 India Ischemia Reperfusion Injury Market Status and Outlook
- 1.3 Ischemia Reperfusion Injury Market by Pipeline
- 1.3.1 Phase 2
- 1.3.2 Phase 1
- 1.3.3 Preclinical
- 1.3.4 Considerations for both Early and Late Phase Clinical Trials
- 1.3.5 Considerations for Early Phase Clinical Trials
- 1.3.6 Considerations for Late Phase Clinical Trials
- 2 Global Ischemia Reperfusion Injury Competition Analysis by Players
- 2.1 Global Ischemia Reperfusion Injury Products and Pipeline by Players
- 2.2 Competitive Status and Trend
- 2.2.1 Market Concentration Rate
- 2.2.2 Product/Service Differences
- 2.2.3 Manufacturers Ischemia Reperfusion Injury Headquarters and Established Date
- 2.2.4 The Technology Trends in Future
- 3 Analysis of Ischemia Reperfusion Injury Industry Key Manufacturers
- 3.1 Angion Biomedica
- 3.1.1 Company Profile
- 3.1.2 Product Information
- 3.1.3 Products and Pipeline
- 3.2 Catalyst Biosciences
- 3.2.1 Company Profile
- 3.2.2 Product Information
- 3.2.3 Products and Pipeline
- 3.3 Ischemix Inc
- 3.3.1 Company Profile
- 3.3.2 Product Information
- 3.3.3 Products and Pipeline
- 3.4 Opsona Therapeutics
- 3.4.1 Company Profile
- 3.4.2 Product Information
- 3.4.3 Products and Pipeline
- 3.5 Pharming
- 3.5.1 Company Profile
- 3.5.2 Product Information
- 3.5.3 Products and Pipeline
- 3.6 TheraSource
- 3.6.1 Company Profile
- 3.6.2 Product Information
- 3.6.3 Products and Pipeline
- 3.7 Bolder Biotechnology
- 3.7.1 Company Profile
- 3.7.2 Product Information
- 3.7.3 Products and Pipeline
- 3.8 Corline Biomedical
- 3.8.1 Company Profile
- 3.8.2 Product Information
- 3.8.3 Products and Pipeline
- 3.9 Mifcortx
- 3.9.1 Company Profile
- 3.9.2 Product Information
- 3.9.3 Products and Pipeline
- 3.10 Balmes Transplantation
- 3.10.1 Company Profile
- 3.10.2 Product Information
- 3.10.3 Products and Pipeline
- 3.11 NovelMed Therapeutics
- 3.11.1 Company Profile
- 3.11.2 Product Information
- 3.11.3 Products and Pipeline
- 3.12 Hope Pharmaceuticals
- 3.12.1 Company Profile
- 3.12.2 Product Information
- 3.12.3 Products and Pipeline
- 3.13 Omeros Corp
- 3.13.1 Company Profile
- 3.13.2 Product Information
- 3.13.3 Products and Pipeline
- 3.14 Prothix
- 3.14.1 Company Profile
- 3.14.2 Product Information
- 3.14.3 Products and Pipeline
- 3.15 SBI Pharmaceuticals
- 3.15.1 Company Profile
- 3.15.2 Product Information
- 3.15.3 Products and Pipeline
- 4 Global Ischemia Reperfusion Injury Market Size by Pipeline
- 4.1 Global Ischemia Reperfusion Injury Pipeline
- 4.2 Top Consumer of Ischemia Reperfusion Injury in Future
- 4.2.1 Sanofi
- 4.2.2 Novo Nordisk
- 4.2.3 Takeda
- 4.2.4 Eli Lilly
- 4.2.5 AstraZeneca
- 4.2.6 Novartis
- 4.2.7 Shire
- 4.2.8 AbbVie
- 4.2.9 Ipsene
- 4.2.10 Allergan
- 4.3 End Users of Ischemia Reperfusion Injury Treatment
- 5 North America Ischemia Reperfusion Injury Pipeline Introduction
- 5.1 BB3
- 5.2 Anti-C3: CB 2782
- 5.3 CMX-2043
- 5.4 rhMFG-E8
- 5.5 BBT-059
- 5.6 MIF-2
- 5.7 Monoclonal Antibodies (MoAbs)
- 5.8 Sodium Nitrite Injection
- 5.9 Omeros¡¯ MASP-3 Inhibitor Program
- 6 Europe Ischemia Reperfusion Injury Pipeline Introduction
- 6.1 OPN-305
- 6.2 RUCONEST
- 6.3 Renaparin
- 6.4 Delayed Graft Function in kindney Transplantation
- 6.5 PRO-02
- 7 Japan Ischemia Reperfusion Injury Pipeline Introduction
- 7.1 5-ALA
- 8 Rest of World Ischemia Reperfusion Injury Pipeline Introduction
- 9 Mechanism of Ischemia and Reperfusion
- 9.1 Symptom of Ischemia Reperfusion Injury
- 9.1.1 Ischemia and Reperfusion Causes Sterile Inflammation
- 9.1.2 Cell Death during Ischemia and Reperfusion
- 9.1.3 Microvascular Dysfunction
- 9.2 Therapeutic Approaches to Enhance Ischemia Tolerance
- 9.2.1 Ischemic Conditioning (Preconditioning, Post conditioning and Remote Conditioning)
- 9.2.2 Metabolic Strategies to Increase Ischemia Tolerance.
- 9.2.3 Therapeutic Gases
- 9.2.4 Nucleotide and Nucleoside Signaling
- 9.2.5 MicroRNAs (miRNAs) as Therapeutic Targets
- 10 Type of Ischemia and Reperfusion Injury
- 10.1 Single-organ Ischemia and Reperfusion
- 10.2 Multiple-organ Ischemia and Reperfusion
- 10.3 Ischemia and Reperfusion during Major Surgery
- 11 Market Forecast by Regions, Product and Application (2025-2035)
- 11.1 Global Ischemia Reperfusion Injury Market Size by Regions (2025-2035)
- 11.1.1 North America Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.1.2 Europe Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.1.3 China Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.1.4 Southeast Asia Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.1.5 India Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.1.6 Japan Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
- 11.2 Global Ischemia Reperfusion Injury Market Size by Application (2025-2035)
- 12 Ischemia Reperfusion Injury Market Dynamics
- 12.1 Ischemia Reperfusion Injury Market Opportunities
- 12.2 Ischemia Reperfusion Injury Challenge and Risk
- 12.2.1 Clinical Phase Costs
- 12.2.2 Capitalized Costs
- 12.2.3 Downside Risks of Economy
- 12.3 Marketing Strategy Analysis, Distributors
- 12.3.1 Marketing Channel
- 12.3.2 Market Positioning
- 13 Market Effect Factors Analysis
- 13.1 Technology Progress/Risk
- 13.1.1 Substitutes
- 13.1.2 Technology Progress in Related Industry
- 13.2 External Environmental Change
- 14 Research Findings and Conclusion
- 15 Methodology and Data Source
- 15.1 Methodology/Research Approach
- 15.1.1 Research Programs/Design
- 15.1.2 Market Size Estimation
- 15.1.3 Market Breakdown and Data Triangulation
- 15.2 Data Source
- 15.2.1 Secondary Sources
- 15.2.2 Primary Sources
- 15.3 Disclaimer
- 15.4 Author List
- List of Tables and Figures
- Figure the Ischemia Reperfusion Injury Example
- Figure Global Ischemia Reperfusion Injury Market Size (M USD) Status and Outlook (2025-2035)
- Table Global Market Ischemia Reperfusion Injury Revenue (M USD) Comparison by Regions 2025-2035
- Figure Global Ischemia Reperfusion Injury Market Share by Regions (2025-2035)
- Figure North America Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure Europe Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure Japan Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure China Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure Southeast Asia Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure India Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Figure Global Ischemia Reperfusion Injury Market Share by Pipeline in 2017
- Table Ischemia Reperfusion Injury on Phase 2
- Table Ischemia Reperfusion Injury on Phase 1
- Table Ischemia Reperfusion Injury on Preclinical
- Table Global Ischemia Reperfusion Injury Products and Pipeline by Players
- Figure Global Ischemia Reperfusion Injury Pipeline by Players in 2017
- Table Product Brands of Major Manufacturers
- Table Manufacturers Ischemia Reperfusion Injury Headquarters and Established Date
- Table Angion Biomedica Company Profile
- Figure Ischemia Reperfusion Injury Product Introduction of Angion Biomedica
- Table Products and Pipeline of Angion Biomedica
- Table Catalyst Biosciences Company Profile
- Figure Ischemia Reperfusion Injury Product Introduction of Catalyst Biosciences
- Table Products and Pipeline of Catalyst Biosciences
- Table Ischemix Inc Company Profile
- Figure The Molecular Structure of CMX-2043
- Table Products and Pipeline of Ischemix Inc
- Table Opsona Therapeutics Company Profile
- Table Products and Pipeline of Opsona Therapeutics
- Table Pharming Company Profile
- Figure Ischemia Reperfusion Injury Product Introduction of Pharming
- Table Products and Pipeline of Pharming
- Table TheraSource Company Profile
- Table Products and Pipeline of TheraSource
- Table Bolder Biotechnology Company Profile
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Bolder Biotechnology
- Table Products and Pipeline of Bolder Biotechnology
- Table Corline Biomedical Company Profile
- Table Products and Pipeline of Corline Biomedical
- Table Mifcortx Company Profile
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Mifcortx
- Table Products and Pipeline of Mifcortx
- Table Balmes Transplantation Company Profile
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Balmes Transplantation
- Table Products and Pipeline of Balmes Transplantation
- Table NovelMed Therapeutics Company Profile
- Figure Ischemia Reperfusion Injury Product Picture of NovelMed Therapeutics
- Table Products and Pipeline of NovelMed Therapeutics
- Table Hope Pharmaceuticals Company Profile
- Table Products and Pipeline of Hope Pharmaceuticals
- Table Omeros Corp Company Profile
- Table Products and Pipeline of Omeros Corp
- Table Prothix Company Profile
- Table Products and Pipeline of Prothix
- Table SBI Pharmaceuticals Company Profile
- Table Products and Pipeline of SBI Pharmaceuticals
- Table Ischemia Reperfusion Injury on Phase 2
- Table Ischemia Reperfusion Injury on Phase 1
- Table Ischemia Reperfusion Injury on Preclinical
- Figure Global Ischemia Reperfusion Injury by Pipeline in 2017
- Table Sanofi Company Profile
- Table Novo Nordisk Company Profile
- Table Takeda Company Profile
- Table Eli Lilly Company Profile
- Table AstraZeneca Company Profile
- Table Novartis Company Profile
- Table Shire Company Profile
- Table AbbVie Company Profile
- Table Ipsen Company Profile
- Table Allergan Company Profile
- Table Top Consumer / End Users of Ischemia Reperfusion Injury
- Figure Ischemia Reperfusion Injury Product Introduction of Angion Biomedica
- Figure Ischemia Reperfusion Injury Product Introduction of Catalyst Biosciences
- Figure The Molecular Structure of CMX-2043
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Bolder Biotechnology
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Mifcortx
- Figure Ischemia Reperfusion Injury Product Picture of NovelMed Therapeutics
- Figure Ischemia Reperfusion Injury Product Introduction of Pharming
- Figure Ischemia Reperfusion Injury Product Picture and Specifications of Balmes Transplantation
- Figure Biological Processes Implicated in Ischemia and Reperfusion
- Figure Therapeutic Gases for the Treatment of Ischemia and Reperfusion.
- Figure Nucleotide and Nucleoside Signaling during Ischemia and Reperfusion
- Figure MiRNA Pathways Implicated in Myocardial Ischemia and Reperfusion
- Table Examples of Ischemia and Reperfusion Injury
- Figure Cold Ischemia Time Thresholds in Solid Organ Allografts
- Figure Global Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
- Table Global Ischemia Reperfusion Injury Market Size (M USD) by Regions (2025-2030)
- Table Global Ischemia Reperfusion Injury Market Size (M USD) by Regions (2030-2035)
- Figure Global Ischemia Reperfusion Injury Market Size Share by Regions (2025-2035)
- Figure Global Ischemia Reperfusion Injury Market Size Share by Regions in 2035
- Figure North America Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Figure Europe Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Figure China Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Figure Southeast Asia Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Figure India Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Figure Japan Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
- Table Global Ischemia Reperfusion Injury Market Size (M USD) by Application (2025-2030)
- Table Global Ischemia Reperfusion Injury Market Size (M USD) by Application (2030-2035)
- Figure Global Ischemia Reperfusion Injury Market Size by Application (2025-2035)
- Figure Global Ischemia Reperfusion Injury Market Size by Application in 2035
- Figure typical phases from research to the market for a drug candidate
- Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
- Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
- Figure Global GDP Growth Rate for 2016
- Figure Real GDP Growth 2016-2020 annual Average
- Figure Marketing Channel for Biopharmaceuticals
- Figure Global Activity in Organ Transplantation
- Figure US GDP 2006-2016 (Billion USD)
- Figure US CPI Change 2017-2018
- Figure EU GDP 2006-2016 (Billion USD)
- Figure EU CPI Change 2012-2016
- Figure Germany GDP 2006-2016 (Billion USD)
- Figure Germany CPI Change 2017-2018
- Figure UK GDP 2006-2016 (Billion USD)
- Figure UK CPI Change 2017-2018
- Figure Italy GDP 2006-2016 (Billion USD)
- Figure Italy CPI Change 2017-2018
- Figure Japan GDP 2006-2016 (Billion USD)
- Figure Japan CPI Change 2012-2016
- Figure China GDP 2006-2016 (Billion USD)
- Figure China CPI Change 2017-2018
- Table Research Programs/Design for This Report